- Home
- SIFY vs TCRX Comparison
SIFY vs TCRX Comparison
Compare SIFY & TCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIFY
- TCRX
- Stock Information
- Founded
- SIFY 1995
- TCRX 2018
- Country
- SIFY India
- TCRX United States
- Employees
- SIFY N/A
- TCRX N/A
- Industry
- SIFY Computer Software: Programming Data Processing
- TCRX Biotechnology: Pharmaceutical Preparations
- Sector
- SIFY Technology
- TCRX Health Care
- Exchange
- SIFY Nasdaq
- TCRX Nasdaq
- Market Cap
- SIFY 232.6M
- TCRX 257.5M
- IPO Year
- SIFY 1999
- TCRX 2021
- Fundamental
- Price
- SIFY $3.29
- TCRX $2.98
- Analyst Decision
- SIFY
- TCRX Strong Buy
- Analyst Count
- SIFY 0
- TCRX 5
- Target Price
- SIFY N/A
- TCRX $11.40
- AVG Volume (30 Days)
- SIFY 79.8K
- TCRX 435.3K
- Earning Date
- SIFY 01-16-2025
- TCRX 11-12-2024
- Dividend Yield
- SIFY N/A
- TCRX N/A
- EPS Growth
- SIFY N/A
- TCRX N/A
- EPS
- SIFY N/A
- TCRX N/A
- Revenue
- SIFY $443,027,157.00
- TCRX $9,362,000.00
- Revenue This Year
- SIFY N/A
- TCRX N/A
- Revenue Next Year
- SIFY $12.52
- TCRX $4.11
- P/E Ratio
- SIFY $60.04
- TCRX N/A
- Revenue Growth
- SIFY 5.85
- TCRX N/A
- 52 Week Low
- SIFY $1.80
- TCRX $2.60
- 52 Week High
- SIFY $12.30
- TCRX $9.69
- Technical
- Relative Strength Index (RSI)
- SIFY 48.05
- TCRX 32.41
- Support Level
- SIFY $3.06
- TCRX $2.82
- Resistance Level
- SIFY $3.64
- TCRX $3.15
- Average True Range (ATR)
- SIFY 0.20
- TCRX 0.39
- MACD
- SIFY -0.03
- TCRX -0.12
- Stochastic Oscillator
- SIFY 22.22
- TCRX 20.09
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.